MOONWALK Trademark

Trademark Overview


On Monday, October 2, 2023, a trademark application was filed for MOONWALK with the United States Patent and Trademark Office. The USPTO has given the MOONWALK trademark a serial number of 98977271. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, January 2, 2026. This trademark is owned by Moonwalk Biosciences. The MOONWALK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of pharmaceuticals, therapeutics, and biotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, pediatric, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases; Conducting research and clinical trials for others relating to veterinary pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, psychiatric, pulmonary, renal, rep...
moonwalk

General Information


Serial Number98977271
Word MarkMOONWALK
Filing DateMonday, October 2, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, January 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of The word MOONWALK in lower case with the two o's placed diagonally, and the first o that is placed in bottom left smaller than the second o that is placed in the upper right.
Goods and ServicesResearch and development in the field of pharmaceuticals, therapeutics, and biotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, pediatric, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases; Conducting research and clinical trials for others relating to veterinary pharmaceuticals in the fields of age-related, autoimmune, cardiometabolic, cardiovascular, dermatological, endocrine, epigenetic, gastrointestinal, genetic, hematological, hemoglobinopathy, immunological, infectious, liver, metabolic, muscular dystrophy, neurodegenerative, neuropsychiatric, oncological, ophthalmological, psychiatric, pulmonary, renal, reproductive, respiratory, and skeletal diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code042
First Use Anywhere DateWednesday, June 1, 2022
First Use In Commerce DateSunday, January 1, 2023

Trademark Owner History


Party NameMoonwalk Biosciences
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameMoonwalk Biosciences
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Thursday, October 5, 2023NEW APPLICATION ENTERED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 22, 2024ASSIGNED TO EXAMINER
Thursday, May 23, 2024NON-FINAL ACTION WRITTEN
Thursday, May 23, 2024NON-FINAL ACTION E-MAILED
Thursday, May 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 27, 2024FINAL REFUSAL WRITTEN
Tuesday, August 27, 2024FINAL REFUSAL E-MAILED
Tuesday, August 27, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 30, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, December 12, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, December 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 12, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, December 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 11, 2025TEAS STATEMENT OF USE RECEIVED
Friday, July 11, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, January 2, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 11, 2025DIVISIONAL REQUEST RECEIVED
Friday, January 2, 2026DIVISIONAL PROCESSING COMPLETE
Friday, July 11, 2025USE AMENDMENT FILED
Friday, January 2, 2026STATEMENT OF USE PROCESSING COMPLETE